PEPperPRINT GmbH
PEPperPRINT GmbH provides peptide microarrays and services for epitope identification and sequence characterization to gain research insights from antibodies and sera.
Classification
Profile
Funding
Funding details not yet available.
Fundraising & market
Enables epitope identification and sequence characterization of antibodies or sera using PEPperCHIP® Peptide Microarrays and PEPperMAP® Services.
Research organizations and biopharma companies requiring detailed antibody characterization and epitope mapping services.
Sells specialized peptide microarrays and provides custom sequence characterization services.
Direct sales via company website and contact information in Heidelberg, Germany.
Spin-off from the German Cancer Research Center (DKFZ), leveraging its research heritage and IP.
R&D for peptide array technology and service operations; specific cost drivers are not detailed in the snippets.
Proprietary IP platform, PEPperCHIP® technology, and a team of experts founded in 2001.
Developing peptide microarrays, performing epitope identification, and conducting sequence characterization for clients.
B2B service model; specific acquisition or retention strategies are not detailed in the snippets.
Specialized provider of peptide microarrays; specific competitors are not named in the snippets.
Need for meaningful research insights regarding antibody specificity and epitope mapping in protein sequences.
- Introduce Tiered SaaS Analytics - Offer a basic free dashboard for academic users and a premium “AI-enhanced epitope prediction” tier for
Differentiation through Speed & Density - Maintaining the technology lead is essential; continuous R&D investment (≈15 % of revenue) will pr · Shift Toward Recurring Revenue - Moving from pure product sales to service/subscription models improves predictability and valuation multipl · Regulatory Positioning - ISO certification and GLP-ready process
No investors recorded yet.